Health
Longer gap in Pfizer-BioNTech COVID vaccines boosts antibody levels: Study – THE WEEK
What is very clear is that two doses are required to maximise protection
A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune responses, UK researchers have found.
The study, led by the University of Oxford, in collaboration with the Universities of Birmingham,…
Continue Reading
-
Noosa News23 hours agoHockey coach in Arana Hills charged with grooming and sexual offences against teenage girls
-
General23 hours agoWoman killed and man injured in shark attack on NSW Mid North Coast
-
Noosa News24 hours agoIKEA and Tekla Are Launching a Whimsical New Collection
-
Business23 hours agoWhy EOS shares could rise 75% in just a year